Results: Hypocalcemia occurred in 3.2% (2 of 62) patients with LVD and 10.4% (8 of 77) patients with OVD (OR 0.2875, P = .124). No patients with vitamin D deficiency (VDD), defined as 25OHD ≤35 nmol/L (14 ng/mL), developed hypocalcemia. Univariate analysis did not show age, sex, malignancy, presence of thyroiditis, number of preserved parathyroids, parathyroid autotransplantation, preoperative PTH, or preoperative calcium to be significantly predictive. Multivariate analysis confirmed no confounding factors in vitamin D analysis, but also did not show any independent risk factors. Fisher analysis comparing total versus completion thyroidectomy was marginally significant (P = .064) for predicting hypocalcemia.
Head and Neck Surgery
Mammary analogue Secretory Carcinoma of the Parotid Gland Lilleen M. Huang, MBBS, MRCS (presenter); Frederik Petersson, MD; David Loke, MD Objective: Mammary analogue secretory carcinoma is a new entity in salivary gland tumors that has only been recently described. It has overlapping histopathological features with acinic cell carcinoma and low grade variants of cystadenocarcinoma. It has a distinct chromosomal translocation, t(12;15)-(p13;q25), resulting in a fusion gene ETV6 NTRK3. The clinical course of this disease entity is uncertain at present. We present a case of MASC of the parotid gland occurring in a 34-year-old man and discuss the difficulties in diagnosis and subsequent treatment of this tumour.
Head and Neck Surgery Management of Oral Ranula
Hyun-Jae Woo, MD (presenter); Deok Hwan Chi, MD Objective: Preferred treatment of oral ranulas remains controversial. We present our experience with ranulas at Gumi CHA Medical Center (GCMC) and review the literature. Results: In the GCMC series, procedures for oral ranulas varied from ranula excision (9 cases, 32%), marsupialization (18 cases), combined ranula and sublingual gland excision (24 cases, 45%), sclerotherapy with OK-432 (10 cases, 23%). Recurrences of ranula excision only, marsupialization, combined ranula and sublingual gland excision, and sclerotherapy were 5 cases (56%), 5 cases (28 %), 0 cases (0%), and 5 cases (50%), respectively. Sixty complications were identified from the literature. Recurrence was considered a complication and was most prevalent (68%). Nonrecurrent complications included tongue hypesthesia (12%), bleeding/hematoma (12%), postoperative infection (7%), and Wharton's duct injury (2%). Procedures and associated complication rates were: ranula excision only (20%), marsupialization (20%), combined ranula and sublingual gland excision (13%), and sclerotherapy (57%).
Conclusion: Based on our review, definitive treatment yielding lowest recurrence and complication rates for oral ranulas is transoral excision of the ipsilateral sublingual gland and ranula.
Head and Neck Surgery Metastatic Lymph Node Metastasis Has Predictive Values for Recurrence in Papillary thyroid Carcinoma
Min-Seok Jang (presenter); Young-Ik Son, MD, PhD; Jeong-Hwan Baek; Ki-Nam Park; Dohun Kim Objective: The authors aimed to evaluate the significance of absolute number of lymph node metastasis (LNM) in papillary thyroid microcarcinoma (PTMC) and the metastatic lymph node ratio (the ratio between metastatic lymph node and harvested lymph nodes; MLNR) in the central neck for the prediction of locoregional recurrence.
Method: Through retrospective chart review between 2005 and 2009, 573 patients who underwent total thyroidectomy and central neck dissection and were followed-up more than 36 months were enrolled. Regarding the risk of recurrence, multivariate analyses were performed with the following variables: multiplicity of tumor, extrathyroidal extension, number of harvested lymph nodes.
Results: Both the number of LNM and MLNR exhibited predictive significance toward locoregional recurrence (P < .001). The lowest cutoff value of MLNR for a meaningful separation of disease recurrence was 0.44 (HR = 8.86, 95% CI = 1.49-52.58, P = .001) when 3 or more lymph nodes were harvested.
Conclusion: Both the number of LNM and MLNR in the central neck have predictive values for loco-regional recurrence. When MLNR is higher than 0.44, there is an increased risk of locoregional recurrence with a HR of 8.86. These findings will supplement in further risk-stratification of locoregional recurrence.
